Primary hepatic malignancy: the role of liver transplantation. 1990

T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
Liver Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.

Between January 1982 and April 1989, 134 patients with a suspected liver neoplasm were referred to the liver unit, Queen Elizabeth Hospital, Birmingham. In 105 (78 per cent), a primary hepatic neoplasm was histologically confirmed, and 47 patients (45 per cent) proved to have primary hepatocellular carcinoma. Twenty-nine orthotopic liver transplants were performed in 28 of these patients (27 per cent). Twenty patients (71 per cent) survived 30 days or longer (median 11.5 months; range 2-87 months), of whom nine are currently alive. We retrospectively analysed our data to determine the influence of preoperative evaluation, histological type and staging on outcome. Computed tomography proved to be superior to intraoperative assessment (86 versus 58 per cent) in diagnosing tumour positive nodes. Patients with tumour negative lymphadenopathy had a better prognosis. Postoperative stage I/II had a median survival of 16 months (range 3-87 months) compared with 7.5 months (range 2-20 months) for stage III. Non-cirrhotic patients with hepatocellular carcinoma had the best prognosis; cholangiocellular carcinoma and cirrhotic patients with hepatocelluar carcinoma had the worst outcome with no survivors beyond 1 year. Because of the advanced stage of disease at the time of presentation, the value of liver transplantation in primary liver cancer is limited. For those presenting with advanced disease confined to the liver (stage I/II) in whom conventional hepatic resection is not possible, significant benefit can be achieved in selected cases.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002759 Adenoma, Bile Duct A benign tumor of the intrahepatic bile ducts. Cholangioma,Adenomas, Bile Duct,Bile Duct Adenoma,Bile Duct Adenomas,Cholangiomas

Related Publications

T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
August 2000, Clinics in liver disease,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
November 1998, Transplantation proceedings,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
January 2001, Tumori,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
January 1982, World journal of surgery,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
February 1992, Transplantation proceedings,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
January 1987, Bailliere's clinical gastroenterology,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
November 1984, The Japanese journal of surgery,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
April 2006, Surgery,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
January 2000, Seminars in liver disease,
T Ismail, and L Angrisani, and B K Gunson, and S G Hübscher, and J A Buckels, and J M Neuberger, and E Elias, and P McMaster
November 2007, The British journal of surgery,
Copied contents to your clipboard!